No Picture
Los Angeles Biotech News

NTS Celebrates 60 Years as Global Leader in Testing, Certification, and Inspection

ANAHEIM, Calif.–(BUSINESS WIRE)– #60YearsofInnovation–National Technical Systems, Inc. (“NTS”), the leading independent provider of qualification testing, inspection, and certification solutions in North America, is proud to announce that the compan… […]

No Picture
Los Angeles Biotech News

MarketingRx roundup: AbbVie’s Humira TV turns focus to HS skin condition; Sanofi amps parenting policy

After years as the top spending pharma TV advertiser, AbbVie’s Humira brand finally downshifted earlier this year, ceding much of its marketing budget to up-and-coming sibling meds Skyrizi and Rinvoq. However, now Humira is back on TV with ads for anot… […]

No Picture
Los Angeles Biotech News

CytRx Provides a Bold Vision on Centurion BioPharma’s Plans for a State-of-the-Art Cancer Center in Las Vegas, Nevada

LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today issued a presentation… […]

No Picture
Los Angeles Biotech News

CytRx Provides a Bold Vision on Centurion BioPharma’s Plans for a State-of-the-Art Cancer Center in Las Vegas, Nevada

LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today issued a presentation… […]

No Picture
Los Angeles Biotech News

GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021

BEVERLY HILLS, Calif.: BEVERLY HILLS, Calif., Nov. 30, 2021 /PRNewswire/ — GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s propr… […]

No Picture
Los Angeles Biotech News

How to use registry data to support FDA decision making: Agency explains in new guidance

Drugmakers looking to design a new registry or use an existing one to support a regulatory decision on a drug’s effectiveness or safety will need to consult with a new draft guidance released Monday by the FDA. The agency’s reliance on registry data fo… […]

No Picture
Los Angeles Biotech News

Amgen Named To Dow Jones Sustainability World Index For Eighth Consecutive Year

THOUSAND OAKS, Calif.: THOUSAND OAKS, Calif., Nov. 29, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it has been named to the Dow Jones Sustainability World Index for the eighth consecutive year, reflecting the company’s enduring commit… […]